Abstract
Study objectives
Many clinicians believe that continuous positive airway pressure (CPAP) therapy of obstructive sleep apnea (OSA) is associated with a decrease in body mass, but to date, studies generally suggest long-term stability in body mass after 1 year. We have seen body mass increase after 4 weeks of treatment with CPAP in most patients with OSA. In this study, we test the hypothesis that therapy of OSA with CPAP produces a short-term gain in body mass, and look for physiological correlates to suggest an underlying mechanism.
Methods
Retrospective analysis of 218 consecutive patients treated for sleep apnea at a community-based sleep center.
Results
A total of 152 patients met the criteria for study conclusion. After 1 month of CPAP treatment, 119 subjects (78%) gained mass, including 81% of men and 73% of women. As a group, subjects on CPAP gained 1.4±2.5 kg (mean±SD). The Epworth Sleepiness Scale was reduced after 1 month of CPAP therapy. There was no correlation between gain in body mass and measured parameters. A subgroup of 71 patients remained on therapy. They demonstrated a gain in mass at 4 weeks, which did not persist at 6 months.
Conclusions
CPAP treatment of OSA is associated with gain in body mass at 1 month but not 6 months of therapy. The nature of this gain in mass remains unknown. We believe the gain is due to increased vascular volume, and might represent an early marker of physiological benefit of CPAP. This article includes a review of potential mechanisms for early increase in body mass with CPAP.
Zusammenfassung
Fragestellung
Viele klinisch tätige Ärzte gehen davon aus, dass eine kontinuierliche Positivdruck (CPAP)-Therapie bei obstruktiver Schlafapnoe (OSA) mit Gewichtsabnahme einhergeht, allerdings legen Studien bis heute eine Langzeitstabilität des Gewichts nach einem Jahr nahe. Wir haben bei den meisten Patienten mit OSA nach 4 Wochen CPAP-Therapie eine Gewichtszunahme beobachtet. In dieser Studie prüfen wir die Hypothese, dass die CPAP-Therapie einer OSA mit einer kurzfristigen Gewichtszunahme einhergeht, und versuchen, physiologische Korrelate für mögliche zugrunde liegende Pathomechanismus zu finden.
Methoden
Retrospektive Untersuchung von 218 konsekutiven Patienten, die gegen Schlafapnoe in einem kommunalen Schlafzentrum behandelt wurden.
Ergebnisse
Den Einschlusskriterien der Studie entsprachen 152 Patienten. Nach einer einmonatigen CPAP-Behandlung war bei 119 (78%; 81% der Männern und 73% der Frauen), eine Gewichtszunahme erfolgt (1,4±2,5 kg, Mittelwert ± Standardabweichung: 1,4±2,5 kg). Die Epworth-Schläfrigkeitsskala war nach einem Monat der CPAP-Therapie reduziert. Es gab keine Korrelation zwischen der Körpergewichtszunahme und den gemessenen Parametern. Eine Untergruppe von 71 Patienten führte die Therapie fort. Sie demonstrierten Gewichtszunahme nach 4 Wochen, die sich nicht über 6 Monate hielt.
Schlussfolgerungen
Die CPAP-Behandlung einer OSA ging mit einer Gewichtszunahme innerhalb des ersten Monats einher, die sich nicht über 6 Monate hielt. Die Ursache dafür bleibt unklar. Wir glauben, dass die Gewichtszunahme durch eine Vergrößerung des Gefäßvolumens verursacht wird und dies ein frühes Merkmal für eine physiologische Kompensation sein könnte. Die Diskussion beinhaltet eine Übersicht über die möglichen Mechanismen für die frühe Gewichtszunahme bei der Anwendung von CPAP.
Similar content being viewed by others
References
Traviss KA, Barr SI, Fleming JA, Ryan CF (2002) Lifestyle-related weight gain in obese men with newly diagnosed obstructive sleep apnea. J Am Diet Assoc 102:703–706
Phillips BG, Hisel TM, Kato M et al (1999) Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17:1297–1300
Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31(Suppl 2):S303–S309
Ip MS, Lam B, Ng MM et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676
Punjabi NM, Sorkin JD, Katzel LI et al (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682
Punjabi NM, Shahar E, Redline S et al (2004) Sleep-disordered breathing, glucose intolerance and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530
Harsch IA, Konturek PC, Koebnick C et al (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257
Hong S, Dimsdale JE (2003) Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med Sci Sports Exerc 35:1088–1092
Loube DI, Loube AA, Erman MK (1997) Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 97:896–897
Redenius R, Murphy C, O’Neill E et al (2008) Does CPAP lead to change in BMI? J Clin Sleep Med 4:205–209
Engleman HM, Asgari-Jirhandeh N, McLeod AL et al (1996) Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 109:1470–1476
Ryan CF, Love LL, Buckley PA (1995) Energy expenditure in obstructive sleep apnea. Sleep 18:180–187
Engleman HM, Gough K, Martin SE et al (1996) Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep 19:378–381
Hein H, Kirsten D, Magnussen H (1997) Nehmen Patienten mit obstruktivem Schlafapnoesyndrom unter nCPAP-Therapie ab? Pneumologie 51(Suppl 3):776–778
Chin K, Shimizu K, Nakamura T et al (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712
Harsch IA, Schahin SP, Radespiel-Troger M et al (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162
Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al (2006) Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129:1459–1467
Trenell MI, Ward JA, Yee BJ et al (2007) Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 9:679–687
Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:142–161
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system of sleep stages in human subjects. Brain Information Service/Brain Research Institute, University of California, Los Angeles
Stenlof K, Grunstein R, Hedner J, Sjostrom L (1996) Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 271:E1036–E1043
Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537–556
Cooper BG, White JE, Ashworth LA et al (1995) Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18:172–179
Thum T, Fleissner F, Klink I et al (2007) Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 92:4172–4179
Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66
Krieger J, Imbs JL, Schmidt M, Kurtz D (1988) Renal function in patients with obstructive sleep apnea. Effects of nasal continuous positive airway pressure. Arch Intern Med 148:1337–1340
Follenius M, Krieger J, Krauth MO et al (1991) Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 14:211–217
Umlauf MG, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7:403–411
Umlauf MG, Chasens ER, Greevy RA et al (2004) Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 27:139–144
Baruzzi A, Riva R, Cirignotta F et al (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14:83–86
Krieger J, Follenius M, Sforza E et al (1991) Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond) 80:443–449
Krieger J, Laks L, Wilcox I et al (1989) Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci (Lond) 77:407–411
Lin CC, Tsan KW, Lin CY (1993) Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep 16:37–39
Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904
Coy TV, Dimsdale JE, Ancoli-Israel S, Clausen J (1996) Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res 5:42–50
Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA (1996) Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153:1333–1338
Khoo MC, Kim TS, Berry RB (1999) Spectral indices of cardiac autonomic function in obstructive sleep apnea. Sleep 22:443–451
Acknowledgments
We thank the staff of the Regional Center for Sleep Medicine of Toledo, OH. This research was supported by the Metabolic Research and Teaching Fund at University of Toledo.
Author information
Authors and Affiliations
Corresponding author
Additional information
Research Site: University of Toledo College of Medicine, Toledo, OH.
Rights and permissions
About this article
Cite this article
Bourey, R., Bourey, J., Habbal, N. et al. Early gain in body mass with continuous positive airway pressure therapy for obstructive sleep apnea. Somnologie 14, 207–212 (2010). https://doi.org/10.1007/s11818-010-0483-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11818-010-0483-8
Keywords
- Sleep apnea
- Obstructive
- Continuous positive airway pressure
- Weight gain
- Obesity
- Hypertension
- Body mass index